Assignee
VEGENICS LTD
AU·19 granted patents·9 pending applications·194 citations·filing 1998–2010
Top patents by PatentIndex Score
28 records- 0196US7855178B2Growth factor binding constructs materials and methodsVEGENICS LTD·Filed 2008·Granted Dec 21, 2010·24 cites·12 claims
- 0294US7423125B2Antibodies to VEGF-CVEGENICS LTD·Filed 2004·Granted Sep 9, 2008·39 cites·36 claims
- 0393US7785803B2Antibody diagnostic kits and methods of useVEGENICS LTD·Filed 2007·Granted Aug 31, 2010·14 cites·6 claims
- 0492US7422741B2VEGFR-3 fusion proteinsVEGENICS LTD·Filed 2005·Granted Sep 9, 2008·19 cites·17 claims
- 0592US7410639B2Vascular endothelial growth factor D(VEGF-D) antibodies and methods of useVEGENICS LTD·Filed 2002·Granted Aug 12, 2008·25 cites·33 claims
- 0687US7829091B2Therapy targeting FLT4 (VEGER-3) expressed in blood vesselsVEGENICS LTD·Filed 2004·Granted Nov 9, 2010·10 cites·60 claims
- 0787US7662932B2Vascular endothelial growth factor D (VEGF-D) polypeptides and methods of useVEGENICS LTD·Filed 2007·Granted Feb 16, 2010·6 cites·3 claims
- 0886US7794756B1Methods of using antibodies to VEGF-CVEGENICS LTD·Filed 2007·Granted Sep 14, 2010·5 cites·7 claims
- 0986US7709270B2Vascular endothelial growth factor C (VEGF-C) protein diagnosticVEGENICS LTD·Filed 2007·Granted May 4, 2010·5 cites·10 claims
- 1085US7871798B2Mammalian cells that express VEGF-D polypeptidesVEGENICS LTD·Filed 2007·Granted Jan 18, 2011·3 cites·13 claims
- 1184US7829536B2Method of treating lymphedema comprising administering VEGF-DVEGENICS LTD·Filed 2009·Granted Nov 9, 2010·3 cites·8 claims
- 1281US7611711B2VEGFR-3 inhibitor materials and methodsVEGENICS LTD·Filed 2002·Granted Nov 3, 2009·18 cites·23 claims
- 1380US7727761B2Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereofVEGENICS LTD·Filed 2004·Granted Jun 1, 2010·8 cites·17 claims
- 1474US7846437B2Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using sameVEGENICS LTD·Filed 2008·Granted Dec 7, 2010·1 cites·4 claims
- 1572US7534572B2Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissueVEGENICS LTD·Filed 2003·Granted May 19, 2009·8 cites·11 claims
- 1668US2011059890A1Expression vectors and cell lines expressing vascular endothelial growth factor d, and method of treating melanomasVEGENICS LTD·Filed 2009·Application pending·0 cites
- 1766US7887800B2Methods for inhibiting VEGF-DVEGENICS LTD·Filed 2008·Granted Feb 15, 2011·0 cites·6 claims
- 1858US7479270B2Methods and compositions for activating VEGF-D and VEGF-CVEGENICS LTD·Filed 2003·Granted Jan 20, 2009·0 cites·11 claims
- 1958US2009017011A1Modulation of vegf-c/vegfr-3 interactions in the treatment of rheumatoid arthritisVEGENICS LTD·Filed 2008·Application pending·0 cites
- 2058US2011142839A1Treatment of pulmonary edemaVEGENICS LTD·Filed 2009·Application pending·0 cites
- 2155US2008317723A1Lymphatic endothelial cells materials and methodsVEGENICS LTD·Filed 2008·Application pending·0 cites
- 2254US2010041605A1Use of VEGF-C or VEGF-D in Reconstructive SurgeryVEGENICS LTD·Filed 2009·Application pending·0 cites
- 2354US2011269146A1Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating MelanomasVEGENICS LTD·Filed 2010·Application pending·0 cites
- 2453US2011243912A1Growth Factor Binding Constructs Materials and MethodsVEGENICS LTD·Filed 2010·Application pending·0 cites
- 2551US7947472B2Expression vectors and cell lines expressing vascular endothelial growth factor DVEGENICS LTD·Filed 1998·Granted May 24, 2011·6 cites·8 claims
- 2650US2011189170A1Chimeric Anti-VEGF-D Antibodies and Humanized Anti-VEGF-D Antibodies and Methods of Using the SameVEGENICS LTD·Filed 2010·Application pending·0 cites
- 2747US7420042B2Soluble neuropilin/growth factor receptor fusion proteinsVEGENICS LTD·Filed 2002·Granted Sep 2, 2008·0 cites·5 claims
- 2845US2008267924A1Autologous lymph node transfer in combination with vegf-c or vegf-d growth factor therapy to treat secondary lymphedema and to improve reconstructive surgeryVEGENICS LTD·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VEGENICS LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →